(Q46925293)

26 December 2017

title

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans (English)

1 reference

26 December 2017

author name string

Nobuaki Ito

1

1 reference

26 December 2017

Seiji Fukumoto

2

1 reference

26 December 2017

Yasuhiro Takeuchi

3

1 reference

26 December 2017

Shu Takeda

4

1 reference

26 December 2017

Hisanori Suzuki

5

1 reference

26 December 2017

Takeyoshi Yamashita

6

1 reference

26 December 2017

Toshiro Fujita

7

1 reference

26 December 2017

publication date

25 October 2007

1 reference

26 December 2017

Journal of Bone and Mineral Metabolism

published in

1 reference

26 December 2017

volume

25

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

419-422

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00774-007-0779-3

exact match

0 references

cites work

A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis

1 reference

12 December 2020

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

1 reference

12 December 2020

Serum FGF23 levels in normal and disordered phosphorus homeostasis.

1 reference

12 December 2020

FGF-23 is elevated by chronic hyperphosphatemia

1 reference

12 December 2020

Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia

1 reference

12 December 2020

A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis

1 reference

12 December 2020

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

1 reference

12 December 2020

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

1 reference

12 December 2020

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

12 December 2020

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

1 reference

12 December 2020

Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism

1 reference

12 December 2020

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

1 reference

12 December 2020

DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.

1 reference

12 December 2020

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

12 December 2020

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

12 December 2020

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

1 reference

12 December 2020

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

1 reference

12 December 2020

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice

1 reference

12 December 2020

A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification

1 reference

12 December 2020

FGF-23 in patients with end-stage renal disease on hemodialysis

1 reference

12 December 2020

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

12 December 2020

10.1007/S00774-007-0779-3

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017